457 related articles for article (PubMed ID: 12093740)
21. Skp2-mediated p27(Kip1) degradation during S/G2 phase progression of adipocyte hyperplasia.
Auld CA; Fernandes KM; Morrison RF
J Cell Physiol; 2007 Apr; 211(1):101-11. PubMed ID: 17096381
[TBL] [Abstract][Full Text] [Related]
22. GA-binding protein regulates KIS gene expression, cell migration, and cell cycle progression.
Crook MF; Olive M; Xue HH; Langenickel TH; Boehm M; Leonard WJ; Nabel EG
FASEB J; 2008 Jan; 22(1):225-35. PubMed ID: 17726090
[TBL] [Abstract][Full Text] [Related]
23. Cyclin D1 regulates p27(Kip1) stability in B cells.
Bustany S; Tchakarska G; Sola B
Cell Signal; 2011 Jan; 23(1):171-9. PubMed ID: 20837141
[TBL] [Abstract][Full Text] [Related]
24. Cloning and functional expression of a degradation-resistant novel isoform of p27Kip1.
Hirano K; Hirano M; Zeng Y; Nishimura J; Hara K; Muta K; Nawata H; Kanaide H
Biochem J; 2001 Jan; 353(Pt 1):51-57. PubMed ID: 11115398
[TBL] [Abstract][Full Text] [Related]
25. Minimal requirements for the nuclear localization of p27(Kip1), a cyclin-dependent kinase inhibitor.
Zeng Y; Hirano K; Hirano M; Nishimura J; Kanaide H
Biochem Biophys Res Commun; 2000 Jul; 274(1):37-42. PubMed ID: 10903892
[TBL] [Abstract][Full Text] [Related]
26. PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization.
Shin I; Yakes FM; Rojo F; Shin NY; Bakin AV; Baselga J; Arteaga CL
Nat Med; 2002 Oct; 8(10):1145-52. PubMed ID: 12244301
[TBL] [Abstract][Full Text] [Related]
27. Expression and subcellular localization of the cyclin-dependent kinase inhibitor p27(Kip1) in epithelial ovarian cancer.
Hurteau JA; Allison BM; Brutkiewicz SA; Goebl MG; Heilman DK; Bigsby RM; Harrington MA
Gynecol Oncol; 2001 Nov; 83(2):292-8. PubMed ID: 11606087
[TBL] [Abstract][Full Text] [Related]
28. Exploitation of a non-apoptotic caspase to regulate the abundance of the cdkI p27(KIP1) in transformed lymphoid cells.
Frost V; Al-Mehairi S; Sinclair AJ
Oncogene; 2001 May; 20(22):2737-48. PubMed ID: 11420686
[TBL] [Abstract][Full Text] [Related]
29. FoxM1 regulates growth factor-induced expression of kinase-interacting stathmin (KIS) to promote cell cycle progression.
Petrovic V; Costa RH; Lau LF; Raychaudhuri P; Tyner AL
J Biol Chem; 2008 Jan; 283(1):453-460. PubMed ID: 17984092
[TBL] [Abstract][Full Text] [Related]
30. BRCA1 transactivates the cyclin-dependent kinase inhibitor p27(Kip1).
Williamson EA; Dadmanesh F; Koeffler HP
Oncogene; 2002 May; 21(20):3199-206. PubMed ID: 12082635
[TBL] [Abstract][Full Text] [Related]
31. [Overexpression of p27(KIP1) induced by Bak gene leads to the arrest in G(1) phase of HCC-9204 cell line].
Li J; Wang W; Yu X; Yang X; Hou Y
Zhonghua Gan Zang Bing Za Zhi; 2001 Jul; 9 Suppl():27-9. PubMed ID: 11509132
[TBL] [Abstract][Full Text] [Related]
32. Biochemical differences between SUDHL-1 and KARPAS 299 cells derived from t(2;5)-positive anaplastic large cell lymphoma are responsible for the different sensitivity to the antiproliferative effect of p27(Kip1).
Turturro F; Frist AY; Arnold MD; Seth P; Pulford K
Oncogene; 2001 Jul; 20(33):4466-75. PubMed ID: 11494142
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus EBNA3C can disrupt multiple cell cycle checkpoints and induce nuclear division divorced from cytokinesis.
Parker GA; Touitou R; Allday MJ
Oncogene; 2000 Feb; 19(5):700-9. PubMed ID: 10698515
[TBL] [Abstract][Full Text] [Related]
34. Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3 and cytoplasmic localization.
Fujita N; Sato S; Katayama K; Tsuruo T
J Biol Chem; 2002 Aug; 277(32):28706-13. PubMed ID: 12042314
[TBL] [Abstract][Full Text] [Related]
35. p27Kip1 modulates cell migration through the regulation of RhoA activation.
Besson A; Gurian-West M; Schmidt A; Hall A; Roberts JM
Genes Dev; 2004 Apr; 18(8):862-76. PubMed ID: 15078817
[TBL] [Abstract][Full Text] [Related]
36. Akt regulates nuclear/cytoplasmic localization of tuberin.
Rosner M; Freilinger A; Hengstschläger M
Oncogene; 2007 Jan; 26(4):521-31. PubMed ID: 16862180
[TBL] [Abstract][Full Text] [Related]
37. Mutations of phosphorylation sites Ser10 and Thr187 of p27Kip1 abolish cytoplasmic redistribution but do not abrogate G0/1 phase arrest in the HepG2 cell line.
Guan X; Chen L; Wang J; Geng H; Chu X; Zhang Q; Du L; De W
Biochem Biophys Res Commun; 2006 Sep; 347(3):601-7. PubMed ID: 16842750
[TBL] [Abstract][Full Text] [Related]
38. CDKs as therapeutic targets for the human genetic disease tuberous sclerosis?
Rosner M; Dolznig H; Fuchs C; Siegel N; Valli A; Hengstschläger M
Eur J Clin Invest; 2009 Dec; 39(12):1033-5. PubMed ID: 19744185
[TBL] [Abstract][Full Text] [Related]
39. Phosphorylation of p27Kip1 on serine 10 is required for its binding to CRM1 and nuclear export.
Ishida N; Hara T; Kamura T; Yoshida M; Nakayama K; Nakayama KI
J Biol Chem; 2002 Apr; 277(17):14355-8. PubMed ID: 11889117
[TBL] [Abstract][Full Text] [Related]
40. Akt-dependent T198 phosphorylation of cyclin-dependent kinase inhibitor p27kip1 in breast cancer.
Motti ML; De Marco C; Califano D; Fusco A; Viglietto G
Cell Cycle; 2004 Aug; 3(8):1074-80. PubMed ID: 15280662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
